Allogene Therapeutics, Inc.
ALLO$1.31−2.24% 1D
$1.0452-week range$4.46
Updated . Prices are snapshots and may be delayed.
Allogene Therapeutics, Inc. price chart
−7.42% over 7D
$1.43
$1.24
Oct 18
Oct 20
AI Outlook for Allogene Therapeutics, Inc.
Bearish posture- Long-term trend-34.7% vs 200-day average
- Medium-term trend-26.4% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Allogene Therapeutics, Inc. performance
1D
−2.2%
7D
−10.3%
30D
−22.5%
90D
−26.8%
1Y
+1.6%
About Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2018 (ticker ALLO).
Allogene Therapeutics, Inc. market data
What is the price of Allogene Therapeutics, Inc. today?
Allogene Therapeutics, Inc. (ALLO) is at $1.31, −2.24% on the day.
What is the 52-week range of Allogene Therapeutics, Inc.?
Over the past year Allogene Therapeutics, Inc. has traded between $1.04 and $4.46. It is currently 8% of the way up that range.
Similar stocks
MRNA
Moderna Inc
$218.01−7.2%
IBRX
Immunitybio Inc
$9.18−8.4%
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.47−15.7%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$2.63−6.4%
MDXH
MDxHealth SA
$0.2066−48.4%
SLS
SELLAS Life Sciences Group, Inc.
$9.98−10.9%
IOVA
Iovance Biotherapeutics, Inc.
$13.62−7.0%
PURR
Hyperliquid Strategies Inc.
$9.07−5.6%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.